lobbying_activities: 3005532

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3005532	33bc7c9f-a7fe-48e4-bb93-5a0813ab0b72	Q2	FORBES-TATE	400976792	NOVARTIS, INC.	2023	second_quarter	CPT	Issues related to prescription drug pricing and Intellectual Property (IP); Issues regarding the World Trade Organization's TRIPS Waiver on COVID Vaccines; Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instructions to Committees.	HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2023-07-16T10:36:00-04:00